Letter to the Editor: Kudos to Buddy Carter from Medicare patients
On behalf of Medicare patients in Georgia who rely on long term care (LTC) pharmacies for their prescription medication, I’d like to thank Congressman Buddy Carter, R-Ga., for advocating for increased transparency and fairness in prescription drug pricing.
LTC pharmacies that oversee the prescriptions for patients in skilled nursing, assisted living facilities and other long term care settings, are beholden to Pharmacy Benefit Managers (PBMs) – the middle men who oversee the pricing structure and reimbursement rate for most generic drugs dispensed by LTC pharmacies to Medicare beneficiaries under the Part D benefit.
Data demonstrates that the pricing methodologies used by these PBMs leads to arbitrary and inadequate reimbursement that puts independent LTC pharmacies and their patients at extreme risk — all while increasing profits for PBMs and the pharmacies they operate.
A pharmacist himself, Congressman Carter recently raised important questions about the pricing practices of PBMs at a Congressional hearing on U.S. Prescription drug pricing practices, during which he expressed concern about the current drug marketplace because it creates perverse incentives for PBMs to shut out independent pharmacies at the expense of the American public.
He further called for greater transparency in PBM practices.
Unfortunately, it comes down to the fact that these pricing practices by PBMs undermine the stability of independent LTC pharmacies, increasing the costs to taxpayers and ultimately jeopardizing quality patient care.
Please join me in thanking Congressman Carter for looking out for Georgia’s vulnerable Medicare beneficiaries and helping to ensure they have access to fairly priced medications.
ROBERT WARNOCK
Click here to see the original article on the Savannah Morning News website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.